New York Post · Fri 6 Nov

Friday 6 November

China reportedly recruited AI exec to spy on Jensen Huang

STKP210_JENSEN_HUANG_A

AI-generated summary China reportedly recruited Megaspeed executive Alice Huang to gather intelligence on Nvidia CEO Jensen Huang regarding American artificial intelligence chips. Three House committees requested that Jensen Huang appear for a joint briefing concerning his interactions with Alice Huang.

Also covered by Engadget news.bloomberglaw.com thehill.com axios.com www.nytimes.com aistockwire.com tftc.io Wccftech Investing.com tomshardware.com TechSpot Fox Business CNBC New York Post
+21 moreBloomberg ctech NBC News semafor.com Business Insider www.pcgamer.com TechCrunch Al Jazeera The San Francisco Standard videocardz.com datacenterdynamics.com Fortune Spyglass ABC News iPhone in Canada | Canada’s source for Apple, telecom, tech news, and deals The Independent CBS News WIRED www.bbc.co.uk Ars Technica PYMNTS.com

LeBron James Sent a Y Combinator-Backed Startup a Cease-and-Desist Letter. That May Have Been the Point

AI-generated summary LeBron James sent a cease-and-desist letter to Bron AI after the sports-betting analytics app used an unauthorized artificial intelligence-generated version of his likeness and voice in a promotional video. A spokesperson for James stated that the athlete is not affiliated with the platform, while representatives demanded the company permanently stop using his likeness and remove the advertisement.

Also covered by California Post

Anthropic is making biotech boasts, but scientists are wary of hype around ‘curing cancer’

An image collage containing 3 images, Image 1 shows Dario Amodei, CEO and co-founder of Anthropic, at the World Economic Forum annual meeting, Image 2 shows Andreas Bender speaking at the Oncode Accelerator Summit, Image 3 shows Biochemist Sarah Martin works in a laboratory at Servier Pharmaceuticals, holding a pipette over a test tube

AI-generated summary Anthropic has been promoting its biotechnology initiatives by opening a Bay Area biology lab, purchasing two biotech startups, and partnering with drugmakers such as Novo and Bristol Myers Squibb. While CEO Dario Amodei has made bold predictions about biological progress and curing cancer, medical professionals and industry experts warn that most drugs fail in clinical trials.